Cargando…
Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost
PURPOSE: Pharmacist-led medication therapy disease management (MTDM) has shown improvement in clinical outcomes in patients with certain chronic diseases. However, only limited data demonstrating the impact on health care utilization and cost of care are available. This study seeks to evaluate the i...
Autores principales: | Maeng, Daniel D, Graham, Jove, Bogart, Michael, Hao, Jing, Wright, Eric A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161711/ https://www.ncbi.nlm.nih.gov/pubmed/30288070 http://dx.doi.org/10.2147/CEOR.S174595 |
Ejemplares similares
-
Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care
por: Dineen-Griffin, Sarah, et al.
Publicado: (2020) -
Impact of a Pharmacist-Led Diabetes Management Intervention to Improve Health Equity
por: Smith-Ray, Renae, et al.
Publicado: (2021) -
Impact of pharmacist-led medication management in care transitions
por: Yang, Seungwon
Publicado: (2017) -
Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
por: Alghadeer, Sultan M., et al.
Publicado: (2021) -
A Review of Pharmacist-led Interventions on Diabetes Outcomes: An Observational Analysis to Explore Diabetes Care Opportunities for Pharmacists
por: Iqbal, Muhammad Z., et al.
Publicado: (2019)